A case-control study of bronchial asthma associated with ulcerative colitis: Role of airway microvascular permeability

Clinical and Experimental Allergy

Volumn 35, Issue 11, 2005, Pages 1432-1436

  Kanazawa, H ^a   Yoshikawa, J ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Airway hyper responsiveness; Inflammatory bowel disease; Microcirculation; Vascular endothelial growth factor

Indexed keywords

METHACHOLINE; NITRIC OXIDE; VASCULOTROPIN; METHACHOLINE CHLORIDE; VASCULOTROPIN A;

ARTICLE; ASTHMA; BLOOD VESSEL PERMEABILITY; BRONCHUS HYPERREACTIVITY; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EOSINOPHIL; FEMALE; HUMAN; INFLAMMATION; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROVOCATION TEST; ULCERATIVE COLITIS; ADULT; CAPILLARY PERMEABILITY; CHEMISTRY; CYTOLOGY; IMMUNOLOGY; INHALATION TEST; LEUKOCYTE COUNT; METHODOLOGY; MICROCIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RESPIRATORY SYSTEM; SPUTUM; VASCULARIZATION;

ADULT; ASTHMA; BRONCHIAL PROVOCATION TESTS; CAPILLARY PERMEABILITY; COLITIS, ULCERATIVE; EOSINOPHILS; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; METHACHOLINE CHLORIDE; MICROCIRCULATION; NITRIC OXIDE; RESPIRATORY SYSTEM; SPUTUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33645228679     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2005.02358.x     Document Type: Article

References (25)

1. Kanazawa H Hirata K Yoshikawa J. Accelerated decline of lung function in COPD patients with chronic hepatitis C virus infection. A preliminary study based on small numbers of patients. Chest 2003 123 : 596 9.
2. Kanazawa H Mamoto T Hirata K Yoshikawa J. Interferon therapy induces the improvement of lung function by inhaled corticosteroid therapy in asthmatic patients with chronic hepatitis C virus infection. A preliminary study. Chest 2003 123 : 600 3.
3. Kanazawa H Yoshikawa J. Accelerated decline in lung function and impaired reversibility with salbutamol in asthmatic patients with chronic hepatitis C virus infection: a 6-year follow-up study. Am J Med 2004 116 : 749 53.
4. Kraft SC Earle RH Rossler M Estarly JR. Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med 1976 136 : 454 9.
5. Mahadeva R Walsh G Flower CDR Shneerson JM. Clinical and radiological characteristics of lung disease in inflammatory bowel disease. Eur Respir J 2000 15 : 41 8.
6. Camus Ph Colby TV. The lung in inflammatory bowel disease. Eur Respir J 2000 15 : 5 10.
7. Tzanakis N Samiou M Bouros D Mouzas J Kouroumalis E Siafakas NM. Small airways function in patients with inflammatory bowel disease. Am J Respir Crit Care Med 1998 157 : 382 6.
8. Higenbottam T Cochrane GM Clark TJH Turner D Millis R Seymour W. Bronchial disease in ulcerative colitis. Thorax 1980 35 : 581 5.
9. Kanazawa H Asai K Hirata K Yoshikawa J. Vascular involvement in exercise-induced airway narrowing in patients with bronchial asthma. Chest 2002 122 : 166 70.
10. Kanazawa H Hirata K Yoshikawa J. Role of endogenous nitric oxide in exercise-induced airway narrowing in patients with bronchial asthma. J Allergy Clin Immunol 2000 106 : 1081 7.
11. Asai K Kanazawa H Kamoi H Shiraishi S Hirata K Yoshikawa J. Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients. Clin Exp Allergy 2003 33 : 595 9.
12. McDonald DM. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 2001 164 : S39 45.
13. Beck PL Podolsky DK. Growth factors in inflammatory bowel disease. Inflamm Bowel Dis 1999 5 : 44 60.
14. Griga T Tromm A Spranger J May B. Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease. Scand J Gastroenterol 1998 33 : 504 8.
15. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987 136 : 225 44.
16. Yoshikawa T Shoji S Fujii T et al. Severity of exercise-induced bronchoconstriction is related to airway eosinophilic inflammation in patients with asthma. Eur Respir J 1998 12 : 879 4.
17. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am J Respir Crit Care Med 1999 160 : 2104 17.
18. Kanazawa H Shoji S Yamada M et al. Increased levels of nitric oxide derivatives in induced sputum in patients with asthma. J Allergy Clin Immunol 1997 99 : 624 9.
19. Adenis A Colombel J-F Lecouffe P et al. Increased pulmonary and intestinal permeability in Crohn's disease. Gut 1992 33 : 678 82.
20. Louis E Louis R Drion V et al. Increased frequency of bronchial hyperresponsiveness in patients with inflammatory bowel disease. Allergy 1995 50 : 729 33.
21. Kanazawa H Hirata K Yoshikawa J. Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients. Thorax 2002 57 : 885 8.
22. Kanazawa H Nomura S Yoshikawa J. Role of microvascular permeability on physiologic differences in asthma and eosinophilic bronchitis. Am J Respir Crit Care Med 2004 169 : 1125 30.
23. H2-mediated sensitization and inflammation in the lung. Nat Med 2004 10 : 1095 03.
24. Busse W Banks-Schlegel S Noel P Ortega H Taggart V Elias J. Future research directions in asthma. An NHLBI working group report. Am J Respir Crit Care Med 2004 170 : 683 90.
25. Birring SS Morgan AJ Prudon B et al. Respiratory symptoms in patients with treated hypothyroidism and inflammatory bowel disease. Thorax 2003 58 : 533 6.